UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Tumor mutational burden in lung cancer: a systematic literature review

Oncotarget, 2019-11, Vol.10 (61), p.6604-6622

2019

Volltextzugriff (PDF)

Measuring Frailty Using Patient-Reported Outcomes (PRO) Data: A Feasibility Study in Patients with Multiple Myeloma

Quality of life research, 2023-08, Vol.32 (8), p.2281-2292

2023

Volltextzugriff (PDF)

Cancer incidence in immunocompromised patients: a single-center cohort study

BMC cancer, 2023-01, Vol.23 (1), p.33-33, Article 33

2023

Volltextzugriff (PDF)

Predictive genomic markers of response to VEGF targeted therapy in metastatic renal cell carcinoma

PloS one, 2019-01, Vol.14 (1), p.e0210415-e0210415

2019

Volltextzugriff (PDF)

Impact of a genetic counseling requirement prior to genetic testing

BMC health services research, 2018-03, Vol.18 (1), p.165-165, Article 165

2018

Volltextzugriff (PDF)

Panobinostat for the treatment of multiple myeloma: the evidence to date

Journal of Blood Medicine, 2015-01, Vol.6 (default), p.269-276

2015

Volltextzugriff (PDF)

PD1/PDL1 inhibitors for the treatment of advanced urothelial bladder cancer

OncoTargets and therapy, 2018-01, Vol.11, p.5973-5989

2018

Volltextzugriff (PDF)

High rifaximin out-of-pocket costs are associated with decreased treatment retention among patients with hepatic encephalopathy

Hepatology communications, 2023-08, Vol.7 (8)

2023

Volltextzugriff (PDF)

Diagnosis and treatment of cancer‐related anemia

American journal of hematology, 2014-02, Vol.89 (2), p.203-212

2014

Volltextzugriff (PDF)

Pharmacist's attitudes and knowledge of pharmacogenomics and the factors that may predict future engagement

Pharmacy practice, 2020-07, Vol.18 (3), p.2008-2008

2020

Volltextzugriff (PDF)

Validation of A Cost-Effectiveness Model Comparing Accuracy of Genetic Tests For Brca Mutations

Value in health, 2016-05, Vol.19 (3), p.A79-A79

2016

Volltextzugriff (PDF)

Competitive Inhibition of Organic Anion Transporting Polypeptide 1c1-Mediated Thyroxine Transport by the Fenamate Class of Nonsteroidal Antiinflammatory Drugs

Endocrinology (Philadelphia), 2009-02, Vol.150 (2), p.1025-1032

2009

Volltextzugriff (PDF)

The Pharmacoeconomics of Breakthrough Cancer Pain

Journal of pain & palliative care pharmacotherapy, 2013-06, Vol.27 (2), p.167-175

2013

Volltextzugriff (PDF)

Electrocatalytic alcohol oxidation by covalently immobilized ruthenium complex on carbon

Journal of inorganic biochemistry, 2022-06, Vol.231, p.111784-111784, Article 111784

2022

Volltextzugriff (PDF)

Integrating pharmacogenetic testing via medication therapy management in an outpatient family medicine clinic

Pharmacogenomics, 2021-03, Vol.22 (4), p.203-212

2021

Volltextzugriff (PDF)

Impact of metformin on tyrosine kinase inhibitor response in chronic myeloid leukemia

Journal of oncology pharmacy practice, 2022-06, Vol.28 (4), p.916-923

2022

Volltextzugriff (PDF)

Quality of Life Outcomes of the United States Chronic Myeloid Leukemia (CML) Patients

Value in health, 2014-05, Vol.17 (3), p.A92-A93

2014

Volltextzugriff (PDF)

Primary Care Clinicians Attitudes and Knowledge of Pharmacogenetics in a Large, Multi-state, Healthcare System

Innovations in pharmacy, 2018-04, Vol.9 (2), p.1-12

2018

Volltextzugriff (PDF)

Targeting Bacteroides in Stool Microbiome and Response to Treatment With First-Line VEGF Tyrosine Kinase Inhibitors in Metastatic Renal-Cell Carcinoma

Clinical genitourinary cancer, 2018-10, Vol.16 (5), p.365-368

2018

Volltextzugriff (PDF)

Pembrolizumab in Advanced Gastrointestinal Malignancies with Defective DNA Mismatch Repair: A Case Series

Journal of Immunotherapy and Precision Oncology, 2018-08, Vol.1 (1), p.1-6

2018

Volltextzugriff (PDF)

Literature Review and Assessment to Populate a Decision-Analytic Model Evaluating a Novel Prognostic in Early Lung Cancer

Value in health, 2013-11, Vol.16 (7), p.A589-A590

2013

Volltextzugriff (PDF)

The United States Physican Survey to Populate a Decision-Analytic Model for the Treatment of Chronic Myeloid Leukemia

Value in health, 2013-11, Vol.16 (7), p.A423-A423

2013

Volltextzugriff (PDF)

Decision Analysis on the Cost-Effectiveness of Sequential Treatment Strategies for Patients with Chronic Myeloid Leukemia in the United States

Value in health, 2014-11, Vol.17 (7), p.A639-A639

2014

Volltextzugriff (PDF)

Can Cost-effectiveness Analysis Inform Genotype-Guided Aspirin Use for Primary Colorectal Cancer Prevention?

Cancer epidemiology, biomarkers & prevention, 2021-06, Vol.30 (6), p.1106-1113

2021

Volltextzugriff (PDF)

SA48 Do 30-Day Out-of-Pocket Costs Influence Rifaximin Treatment Retention in Patients with Hepatic Encephalopathy?

Value in health, 2023-06, Vol.26 (6), p.S405-S406

2023

Volltextzugriff (PDF)

1 – 25 von 214

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(206)
Mit Volltextzugriff
(194)

Publikationsform

Sprache

Englisch
(214)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Tumor mutational burden in lung cancer: a systematic literature review

Measuring Frailty Using Patient-Reported Outcomes (PRO) Data: A Feasibility Study in Patients with Multiple Myeloma

Cancer incidence in immunocompromised patients: a single-center cohort study

Predictive genomic markers of response to VEGF targeted therapy in metastatic renal cell carcinoma

Impact of a genetic counseling requirement prior to genetic testing

Panobinostat for the treatment of multiple myeloma: the evidence to date

PD1/PDL1 inhibitors for the treatment of advanced urothelial bladder cancer

High rifaximin out-of-pocket costs are associated with decreased treatment retention among patients with hepatic encephalopathy

Diagnosis and treatment of cancer‐related anemia

Pharmacist's attitudes and knowledge of pharmacogenomics and the factors that may predict future engagement

Validation of A Cost-Effectiveness Model Comparing Accuracy of Genetic Tests For Brca Mutations

Competitive Inhibition of Organic Anion Transporting Polypeptide 1c1-Mediated Thyroxine Transport by the Fenamate Class of Nonsteroidal Antiinflammatory Drugs

The Pharmacoeconomics of Breakthrough Cancer Pain

Electrocatalytic alcohol oxidation by covalently immobilized ruthenium complex on carbon

Integrating pharmacogenetic testing via medication therapy management in an outpatient family medicine clinic

Impact of metformin on tyrosine kinase inhibitor response in chronic myeloid leukemia

Quality of Life Outcomes of the United States Chronic Myeloid Leukemia (CML) Patients

Primary Care Clinicians Attitudes and Knowledge of Pharmacogenetics in a Large, Multi-state, Healthcare System

Targeting Bacteroides in Stool Microbiome and Response to Treatment With First-Line VEGF Tyrosine Kinase Inhibitors in Metastatic Renal-Cell Carcinoma

Pembrolizumab in Advanced Gastrointestinal Malignancies with Defective DNA Mismatch Repair: A Case Series

Literature Review and Assessment to Populate a Decision-Analytic Model Evaluating a Novel Prognostic in Early Lung Cancer

The United States Physican Survey to Populate a Decision-Analytic Model for the Treatment of Chronic Myeloid Leukemia

Decision Analysis on the Cost-Effectiveness of Sequential Treatment Strategies for Patients with Chronic Myeloid Leukemia in the United States

Can Cost-effectiveness Analysis Inform Genotype-Guided Aspirin Use for Primary Colorectal Cancer Prevention?

SA48 Do 30-Day Out-of-Pocket Costs Influence Rifaximin Treatment Retention in Patients with Hepatic Encephalopathy?

Suchergebnisse filtern